(UF CARE Members, Affiliate Members, and Alumni in Bold)
Berthold EC, Kamble SH, Raju KS, King TI, Popa R, Sharma A, León F, Avery BA, McMahon LR, McCurdy CR. Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method. J Pharm Biomed Anal. 2021 Feb 5;194:113778. doi: 10.1016/j.jpba.2020.113778. Epub 2020 Nov 21. PMID: 33277117
Blanton HL, Barnes RC, McHann MC, Bilbrey JA, Wilkerson JL, Guindon J. Sex differences and the endocannabinoid system in pain. Pharmacol Biochem Behav. 2021 Jan 12;202:173107. doi: 10.1016/j.pbb.2021.173107. Epub ahead of print. PMID: 33444598
Cirino TJ, Alleyne AR, Duarte V, Figueroa A, Simons CA, Anceaume EM, Kendrick J, Wallman O, Eans SO, Stacy HM, Medina JM, McLaughlin JP: Expression of human immunodeficiency virus transactivator of transcription (HIV-Tat1-86) protein alters nociceptive processing that is sensitive to anti-oxidant and anti-inflammatory interventions. (In press, Journal of Neuroimmune Pharmacology; 1-22-2021).
Cottler LB, Goldberger BA, Nixon SJ, Striley CW, Barenholtz E, Fitzgerald ND, Taylor SM, Palamar JJ. Introducing NIDA's New National Drug Early Warning System. Drug Alcohol Depend. 2020 Dec 1;217:108286. doi: 10.1016/j.drugalcdep.2020.108286. Epub 2020 Sep 14. PMID: 32979739; PMCID: PMC7489265.
Lewis, B., Garcia, C. C., Bohan, R., & Nixon, S. J. (2020). Impact of polysubstance use on social and non-affective cognitive performance among treatment-seeking individuals with alcohol use disorders. Addictive Behaviors, 106, 106359. Featured in special issue "New directions in the evaluation and rehabilitation of neurocognitive processes in addictive disorders" PMCID: PMC7400962
Liu Y, Cheong J, Setlow B, Cottler LB. Cocaine and Marijuana Polysubstance Use and Cocaine Use Disorder: Investigating Mediated Effects through Patterns of Cocaine Use. J Dual Diagn. 2020 Dec 10:1-14. doi: 10.1080/15504263.2020.1849887. Epub ahead of print. PMID: 33300839.
Polles, A.G., Bundy, C., Jacobs, W.M., & Merlo, L.J. (2021). Adaptations to substance use disorder monitoring by physician health programs in response to COVID-19. Journal of Substance Abuse Treatment, 125. E-pub ahead of print. doi: https://doi.org/10.1016/j.jsat.2021.108281
Wilson LL, Eans SO, Cirino TJ, Stacy HM, Simons CA, Uprety R, Majumdar S, McLaughlin JP: Kratom alkaloids, natural and semi-synthetic, show less physical dependence and ameliorate opioid withdrawal. In press;Cellular and Molecular Neurobiology; (special issue: “Understanding opioid actions, pain and analgesia: a tribute to Dr. Gavril Pasternak”). 2021 Jan 12. PMID: 33433723.